NCT02782975 Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants Status COMPLETED Phase PHASE1
NCT02778438 A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits Status COMPLETED Phase N/A
NCT02776072 Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase N/A
NCT02739542 Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) Status COMPLETED Phase PHASE4
NCT02730455 Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke Status COMPLETED Phase PHASE2
NCT02691702 Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02686268 Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS Status COMPLETED Phase N/A
NCT02683863 Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers Status COMPLETED Phase PHASE4
NCT02677077 Clinical Disease Activity With Long Term Natalizumab Treatment Status COMPLETED Phase N/A
NCT02675413 Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS Status WITHDRAWN Phase PHASE4
NCT02666963 A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults Status COMPLETED Phase PHASE1
NCT02658916 Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003 Status TERMINATED Phase PHASE1
NCT02657356 Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST Status TERMINATED Phase PHASE3